Paraneoplastic syndrome in vaginal melanoma: A case report and review of the literature

International Journal of Gynecological Cancer

Volumn 17, Issue 5, 2007, Pages 1159-1163

  Hauspy, J ^a   Nevin, A ^a   Harley, I ^a   Mason, W ^b   Quirt, I ^a   Ghazarian, D ^b   Laframboise, S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Melanoma; Paraneoplastic syndrome; Vagina

Indexed keywords

ADULT; CANCER DIAGNOSIS; CANCER SURGERY; CASE REPORT; FEMALE; HUMAN; MELANOMA; MYOCLONUS; OPSOCLONUS; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; REVIEW; VAGINA CANCER;

FEMALE; HUMANS; MELANOMA; MIDDLE AGED; PARANEOPLASTIC SYNDROMES; VAGINAL NEOPLASMS;

EID: 34548684572     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00857.x     Document Type: Review

References (21)

1. Weinstock MA. Malignant melanoma of the vulva and vagina in the United States: patterns of incidence and population-based estimates of survival. Am J Obstet Gynecol 1994 171 : 1225 30.
2. Stang A, Streller B, Eisinger B, Jockel KH. Population-based incidence rates of malignant melanoma of the vulva in Germany. Gynecol Oncol 2005 96 : 216 21.
3. Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW. Primary melanoma of the vagina: a clinicopathologic analysis. Obstet Gynecol 1989 74 : 190 9.
4. Gokaslan H, Sismanoglu A, Pekin T, Kaya H, Ceyhan N. Primary malignant melanoma of the vagina: a case report and review of the current treatment options. Eur J Obstet Gynecol Reprod Biol 2005 121 : 243 8.
5. Androutsopoulos G, Adonakis G, Ravazoula P, Kourounis G. Primary malignant melanoma of the vagina: a case report. Eur J Gynaecol Oncol 2005 26 : 661 2.
6. Signorelli M, Lissoni AA, Garbi A, Perego P, Mangioni C. Primary malignant vaginal melanoma treated with adriamycin and ifosfamide: a case report and literature review. Gynecol Oncol 2005 97 : 700 3.
7. Abu-Shakra M, Buskila D, Ehrenfeld M, Conrad K, Shoenfeld Y. Cancer and autoimmunity: autoimmune and rheumatic features in patients with malignancies. Ann Rheum Dis 2001 60 : 433 41.
8. Allard JE, McBroom JW, Zahn CM, McLeod D, Maxwell GL. Vaginal metastasis and thrombocytopenia from renal cell carcinoma. Gynecol Oncol 2004 92 : 970 3.
9. Forgy AP, Ewing TL, Flaningam J. Two paraneoplastic syndromes in a patient with ovarian cancer: nephrotic syndrome and paraneoplastic cerebellar degeneration. Gynecol Oncol 2001 80 : 96 8.
10. Sais G, Marcoval J, Juggla A, Curco N, Servitje O. Dermatomyositis and metastatic malignant melanoma, with complete regression of the primary lesion. Br J Dermatol 1994 130 : 796 7.
11. Weizman DA, Leong WL. Anti-Ri antibody opsoclonus-myoclonus syndrome and breast cancer: a case report and a review of the literature. J Surg Oncol 2004 87 : 143 5.
12. Lorusso L, Hart IK, Giometto B et al. Immunological features of neurological paraneoplastic syndromes. Int J Immunopathol Pharmacol 2004 17 : 135 44.
13. Cardosi RJ, Decesare SL, Roberts WS. Paraneoplastic cerebellar degeneration and gynecologic malignancies. Int J Gynecol Cancer 1997 7 : 279 83. doi: 10.1046/j.1525-1438.1997.00454.x
14. Hammack JE, Kimmel DW, O'Neill BP, Lennon VA. Paraneoplastic cerebellar degeneration: a clinical comparison of patients with and without Purkinje cell cytoplasmic antibodies. Mayo Clin Proc 1990 65 : 1423 31.
15. Dropcho EJ. Autoimmune central nervous system paraneoplastic disorders: mechanisms, diagnosis, and therapeutic options. Ann Neurol 1995 37 (Suppl. 1 S102 13.
16. Land R, Carter J, Houghton R, Atkinson K, Dalrymple C. Gynaecology meets neurology: paraneoplastic cerebellar degeneration. Aust N Z J Obstet Gynaecol 2005 45 : 79 81.
17. Brock S, Ellison D, Frankel J, Davis C, Illidge T. Anti-Yo antibody-positive cerebellar degeneration associated with endometrial carcinoma: case report and review of the literature. Clin Oncol (R Coll Radiol) 2001 13 : 476 9.
18. Sutton I, Winer JB. The immunopathogenesis of paraneoplastic neurological syndromes. Clin Sci (Lond) 2002 102 : 475 86.
19. Albert ML, Darnell JC, Bender A, Francisco LM, Bhardwaj N, Darnell RB. Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med 1998 4 : 1321 4.
20. Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody. J Neurol Sci 1999 168 : 28 31.
21. Shams'ili S, Grefkens J, de Leeuw B et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain 2003 126 (Pt 6 1409 18.